U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501780) titled 'Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice' on March 16.
Brief Summary: Basal cell carcinoma (BCC) is the most common skin cancer in the Netherlands, with incidence rates continuing to rise. The current diagnostic standard combines clinical evaluation and dermoscopy, while biopsy followed by histopathological examination remains the gold standard when uncertainty about the diagnosis persists. However, biopsy is invasive, time-consuming, and costly. Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive imaging technique that has emerged as a promising alternative to biopsy ...